首页 | 本学科首页   官方微博 | 高级检索  
     


Complete Response to Eribulin in a Patient with Unresectable Liposarcoma: A Case Report and Implications of New Biomarkers
Authors:Hajime Nakamura  Kohichi Takada  Makoto Emori  Naotaka Hayasaka  Shintaro Sugita
Affiliation:1.Department of Medical Oncology, Sapporo Medical University School of Medicine, Japan; 2.Department of Orthopedics, Sapporo Medical University School of Medicine, Japan; 3.Department of Surgical Pathology, Sapporo Medical University School of Medicine, Japan
Abstract:We herein report a rare case of unresectable liposarcoma that showed a complete response to eribulin. Furthermore, a low expression of phosphorylated AKT (p-AKT) on an immunohistological evaluation was observed. This result is consistent with our previous preclinical study that demonstrated the significance of p-AKT signaling for eribulin resistance in multiple subtypes of soft tissue sarcoma (STS) cells. This case highlights the potential benefits of eribulin as well as the mechanism underlying resistance to eribulin in patients with unresectable or metastatic STS, especially liposarcoma.
Keywords:eribulin   liposarcoma   phosphorylated AKT
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号